Avidity Biosciences, Inc.
RNAMDrugs in Pipeline
3
Phase 3 Programs
0
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 0 past
No catalysts found.
Frequently asked questions
What is in Avidity Biosciences, Inc.'s drug pipeline?→
CatalystAlert tracks 3 drug candidates in Avidity Biosciences, Inc.'s (RNAM) pipeline across Phase 2. Its lead program is AOC 1044 (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Avidity Biosciences, Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Avidity Biosciences, Inc. (RNAM) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track RNAM biotech catalysts?→
Add RNAM to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Avidity Biosciences, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.